BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34638956)

  • 1. The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway.
    Sánchez-Sánchez AV; García-España A; Sánchez-Gómez P; Font-de-Mora J; Merino M; Mullor JL
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanog regulates primordial germ cell migration through Cxcr4b.
    Sánchez-Sánchez AV; Camp E; Leal-Tassias A; Atkinson SP; Armstrong L; Díaz-Llopis M; Mullor JL
    Stem Cells; 2010 Sep; 28(9):1457-64. PubMed ID: 20578184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspective: Cooperation of Nanog, NF-κΒ, and CXCR4 in a regulatory network for directed migration of cancer stem cells.
    Es-Haghi M; Soltanian S; Dehghani H
    Tumour Biol; 2016 Feb; 37(2):1559-65. PubMed ID: 26715265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling.
    Goffart N; Kroonen J; Di Valentin E; Dedobbeleer M; Denne A; Martinive P; Rogister B
    Neuro Oncol; 2015 Jan; 17(1):81-94. PubMed ID: 25085362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
    Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
    Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
    Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
    PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
    Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target.
    Terasaki M; Sugita Y; Arakawa F; Okada Y; Ohshima K; Shigemori M
    Brain Tumor Pathol; 2011 Apr; 28(2):89-97. PubMed ID: 21210239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanog promotes stem-like traits of glioblastoma cells.
    Yuan Y; Zhang M; Yan G; Ma Q; Yan Z; Wang L; Yang K; Guo D
    Front Biosci (Landmark Ed); 2021 Jan; 26(3):552-565. PubMed ID: 33049683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells.
    Williams CK; Segarra M; Sierra Mde L; Sainson RC; Tosato G; Harris AL
    Cancer Res; 2008 Mar; 68(6):1889-95. PubMed ID: 18339870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.
    Rao S; Sengupta R; Choe EJ; Woerner BM; Jackson E; Sun T; Leonard J; Piwnica-Worms D; Rubin JB
    PLoS One; 2012; 7(3):e33005. PubMed ID: 22427929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
    do Carmo A; Patricio I; Cruz MT; Carvalheiro H; Oliveira CR; Lopes MC
    Cancer Biol Ther; 2010 Jan; 9(1):56-65. PubMed ID: 19923906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of EGFR Over-expression and Mutations Leading to 
Biological Characteristics Changes of Human Lung Adenocarcinoma Cells 
through CXCR4/CXCL12 Signaling Pathway].
    Feng J; Wei X; Li C; Guo M; Peng M; Song Q; Han G
    Zhongguo Fei Ai Za Zhi; 2018 Jul; 21(7):503-512. PubMed ID: 30037369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.